'High' antiretroviral deintensification strategy and cellular HIV DNA levels

J Chemother. 2020 Feb;32(1):49-51. doi: 10.1080/1120009X.2019.1692996. Epub 2019 Dec 6.

Authors

Massimiliano Lanzafame¹, Emanuela Lattuada², Marcello Vincenzi², Marta Vecchi², Dora Luise², Erica Diani³, Davide Gibellini³

Affiliations

¹ Unità Semplice Organizzativa "Diagnosi e Terapia dell'infezione da HIV", University of Verona, Verona, Italy.
² Unità Complessa di Malattie Infettive, University of Verona, Verona, Italy.
³ Microbiology and Virology Section, Department of Diagnostic and Public Health, University of Verona, Verona, Italy.

PMID: 31809663
DOI: 10.1080/1120009X.2019.1692996

No abstract available

Publication types

Letter

MeSH terms

Alkynes / administration & dosage*
Anti-HIV Agents / administration & dosage*
Antiretroviral Therapy, Highly Active
Benzoxazines / administration & dosage*
Cyclopropanes / administration & dosage*
DNA, Viral / analysis*
HIV Infections / drug therapy*
HIV-1
Humans
Lamivudine / administration & dosage*
Nevirapine / administration & dosage*
Pilot Projects

Substances

Alkynes
Anti-HIV Agents
Benzoxazines
Cyclopropanes
DNA, Viral
Lamivudine
Nevirapine
efavirenz